v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04900415 |
Full text link
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
ivanhung@hku.hk |
Registration date
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2021-05-25 |
Recruitment status
Last imported at : May 6, 2023, 8 p.m. Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Long covid |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: adult out-patient (≥18 years of age) previously diagnosed with coronavirus disease 2019 (covid-19) by laboratory confirmation using reverse transcriptase polymerase chain reaction (rt-pcr) for the detection of severe acute respiratory virus coronavirus 2 (sars-cov-2) complaints of persistent olfactory disturbances, subjectively quantitatively documented to have olfactory dysfunction by butanol threshold test (btt) smell identification test (sit) all subjects give written informed consent subjects must be available to complete the study and comply with study procedures. |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inability to comprehend and to follow all required study procedures allergy or severe reactions to the study drug or smell training pregnant or breastfeeding women pre-existing factors which may account for persistent olfactory dysfunction besides covid-19 (e.g. nasal polyps, obstructive lesions within the nasal cavity, severe anatomical malformations…) received an experimental agent (vaccine, drug, biologic, device, blood product, or medication) within 1 month prior to recruitment in this study or expect to receive an experimental agent during this study. unwilling to refuse participation in another clinical study through the end of this study. have any condition that the investigator believes may interfere with successful completion of the study. |
Number of arms
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
3 |
Funding
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Ivan FN Hung MD |
Inclusion age min
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Hong Kong |
Type of patients
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
Severity scale
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
25 |
primary outcome
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Objective olfactory assessment by the butanol threshold test (BTT);Objective olfactory assessment by the smell identification test (SIT);Subjective olfactory assessment |
Notes
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : May 27, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1656, "treatment_name": "Olfactory training+vitamin a", "treatment_type": "Olfactory training+vitamins and dietary supplements", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 919, "treatment_name": "Olfactory training", "treatment_type": "Olfactory training", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |